Brain Cancer Trial, Not Yet Recruiting (NCT06728150)

Brain Cancer Trial, Not Yet Recruiting NCT06728150 Sponsor: Monash University Condition: Brain Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06728150 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Brain Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have breast cancer that has spread (metastasized) to organs, lymph nodes, or bones
Your breast cancer tests positive for a protein called HER2 (known as HER2-positive)
You have a type of breast cancer called triple negative breast cancer (TNBC) that has spread to other parts of the body
You have hormone receptor-positive breast cancer (ER-positive) that has already been treated with at least two previous treatments, including a specific type of drug called a CDK4/6 inhibitor, and the cancer has spread to more than two areas of bone or to other organs
Your metastatic diagnosis was made within the last 3 months, you currently have no symptoms, and a brain MRI scan has confirmed no signs of disease in the brain
You are eligible for Medicare

Who may not be able to join:

You have cancer that has spread to the brain and is currently causing symptoms
You are unable to give your own consent to participate in the trial
Your organs (such as kidneys, liver, or heart) are not functioning well enough (confirm with trial site)
You are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06728150

Sponsor: Monash University

Phase: Not Applicable

Status: Not Yet Recruiting

Condition: Brain Cancer

More information: https://clinicaltrials.gov/study/NCT06728150

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have breast cancer that has spread (metastasized) to organs, lymph nodes, or bones
Your breast cancer tests positive for a protein called HER2 (known as HER2-positive)
You have a type of breast cancer called triple negative breast cancer (TNBC) that has spread to other parts of the body
You have hormone receptor-positive breast cancer (ER-positive) that has already been treated with at least two previous treatments, including a specific type of drug called a CDK4/6 inhibitor, and the cancer has spread to more than two areas of bone or to other organs
Your metastatic diagnosis was made within the last 3 months, you currently have no symptoms, and a brain MRI scan has confirmed no signs of disease in the brain
You are eligible for Medicare

Who may not be able to join:

You have cancer that has spread to the brain and is currently causing symptoms
You are unable to give your own consent to participate in the trial
Your organs (such as kidneys, liver, or heart) are not functioning well enough (confirm with trial site)
You are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Not Yet Recruiting

Phase

Not Applicable

Sponsor

Monash University

Registry

ClinicalTrials.gov

Start date

1 December 2024

Est. completion

31 December 2029

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Incidence of screen-detected asymptomatic brain metastasis.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov